The effect of Fluocinolone Acetonide Implant (Iluvien) in patients with diabetic macular edema (DME) with prior no, or sub-optimal response to Dexamethasone implants (INDEX Study)

被引：0
|
作者：
Habib, Maged [2 ]
Cheema, Muhammad Raza [1 ]
Tzoumas, Nikolaos [1 ]
Masri, Ibrahim [1 ]
Smith, Jonathan [1 ]
Grinton, Michael Edward [1 ]
Varma, Deepali [1 ]
Steel, David H. W. [1 ,2 ]
Kotagiri, Ajay [1 ]
机构：
[1] Sunderland Eye Infirm, Ophthalmol, Sunderland, Tyne & Wear, England
[2] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Short Term Results of Fluocinolone Acetonide Intravitreal Implant (Iluvien®) for Diabetic Macular Edema in Highly Treated Eyes
    Dhawlikar, Nisha
    Shah, Sumit P.
    Yarian, David L.
    Prenner, Jonathan L.
    Friedman, Eric S.
    Fine, Howard F.
    Wheatley, H. Matthew
    Roth, Daniel B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [22] Effect of the Iluvien implant in patients with recurrent macular edema after treatment with intravitreal dexamethasone implants
    Alagahgi, B.
    van Huet, R. A. C.
    ACTA OPHTHALMOLOGICA, 2022, 100 : 25 - 25
  • [23] REAL-LIFE EFFICACY WITH ILUVIEN® (FLUOCINOLONE ACETONIDE [FAC]) IN DIABETIC MACULAR EDEMA (DME) PATIENTS IN 4 PORTUGUESE OPTHALMOLOGY UNITS
    Meireles, Angelina
    Pessoa, Bernardete
    Coelho, Joao
    Teixeira, Carla
    Falcao, Manuel Alberto
    Goncalves, Rita
    Silva, Marta Ines
    Castro e Sousa, Joao Paulo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [24] Safety and efficacy of fluocinolone acetonide intravitreal implant (Iluvien®) in patients with chronic diabetic macular edema in a real-life setting
    Santos, Monica
    Campos, Antonio
    Neves, Arminda
    Alfaiate, Pedro
    Pereira, Joana
    Castro e Sousa, Joao Paulo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [25] The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema
    Maria Vittoria Cicinelli
    Amir Rosenblatt
    Domenico Grosso
    Piero Zollet
    Luigi Capone
    Alessandro Rabiolo
    Rosangela Lattanzio
    Anat Loewenstein
    Francesco Bandello
    Eye, 2021, 35 : 3232 - 3242
  • [26] Changes in the cup-to-disc ratio in patients with diabetic macular edema (DME) treated with fluocinolone acetonide (FAc) implants
    Parrish, Richard K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [27] The efficacy and safety outcomes of the 0.19 mg fluocinolone acetonide implant after prior treatment with the 0.7 mg dexamethasone implant in patients with diabetic macular edema
    Singh, P.
    Chedid, A.
    Deuchler, S. K.
    Kohnen, T.
    Mueller, M.
    Koch, F. H.
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2018, 11 : 265 - 269
  • [28] Fluocinolone Acetonide (0.19 mcg/day) Intravitreal Implant and Improved Treatment Burden for Patients with Diabetic Macular Edema (DME)
    Byun, Matthew
    Riemann, Christopher D.
    Osher, James
    Patel, Yogin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [29] Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant
    Ciulla, Thomas A.
    Harris, Alon
    McIntyre, Nathaniel
    Jonescu-Cuypers, Christian
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 953 - 959
  • [30] Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN®) in Patients with Diabetic Macular Edema
    Elaraoud I.
    Attawan A.
    Quhill F.
    Ophthalmology and Therapy, 2016, 5 (1) : 95 - 104
12345